[Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer]
- PMID: 17425844
[Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer]
Abstract
Objective: To demonstrate the molecular mechanism of poor prognosis in HER-2 overexpressing breast carcinoma, to study the correlation between angiogenesis/lymphangiogenesis and HER-2, and the effect of them in the progression and prognosis, so as to provide novel molecular markers for lymph node metastasis and prognosis in breast carcinoma.
Methods: (1) By using TaqMan real-time quantitative reverse transcription polymerase chain reaction (real-time qRT-PCR) technique and immunohistochemistry (IHC), the mRNA and protein expression of VEGF-C were detected in SKBR-3 and MDA-MB-231 cell lines before and after the interference with Herceptin. (2) Real-time qRT-PCR was performed to detect the mRNA expression of VEGF-C and -D genes in 67 cases of primary breast infiltrating ductal carcinoma. (3) 160 formalin-fixed paraffin-embedded infiltrating ductal carcinomas were selected. The protein expression of HER-2, VEGF-C, lymphatic vessel density (LVD) and lymphatic vessel invasion (LVI) were detected by IHC.
Result: (1) After interference with Herceptin, the VEGF-C mRNA and protein expression of sKBR-3 the cells decreased significantly. In primary breast cancer, the protein expression of HER-2 was positively correlated with VEGF-C protein expression (r = 0.215, P < 0.05). There was a significantly positive correlation between VEGF-C protein expression and LVD (r = 0.248, P < 0.01). (2) VEGF-C mRNA expression in the patients with lymph node metastasis was higher than that in the patients without lymph node metastasis (1.6 +/- 0.5 vs 1.1 +/- 0.5) (t = 2.196, P < 0.05). Logistic regression model showed HER-2, LVD and LVI were important factors influencing lymph node metastasis (all P < 0.05). (3) Kaplan-Meier analysis indicated that HER-2 protein overexpression, VEGF-C protein overexpression, and high LVD and LVI were associated with patient's worse disease-free survival (P(uni) < 0.05). Cox regression analysis indicated that HER-2 and LVI were the independent prognostic factors of breast cancer (both P(mult) < 0.05).
Conclusion: Through up-regulating VEGF-C expression, HER-2 overexpression induces lymphangiogenesis, promotes metastasis, and results in the poor prognosis of breast cancer. VEGF-C expression, LVD and LVI are novel prognostic indicators of breast cancer.
Similar articles
-
Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer.Breast Cancer Res Treat. 2005 May;91(2):125-32. doi: 10.1007/s10549-004-5783-x. Breast Cancer Res Treat. 2005. PMID: 15868440
-
Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.BMC Cancer. 2008 Jan 13;8:4. doi: 10.1186/1471-2407-8-4. BMC Cancer. 2008. PMID: 18190720 Free PMC article.
-
Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.Anat Rec (Hoboken). 2010 May;293(5):802-12. doi: 10.1002/ar.21096. Anat Rec (Hoboken). 2010. PMID: 20225197
-
Roles of prostaglandins in tumor-associated lymphangiogenesis with special reference to breast cancer.Cancer Metastasis Rev. 2018 Sep;37(2-3):369-384. doi: 10.1007/s10555-018-9734-0. Cancer Metastasis Rev. 2018. PMID: 29858743 Review.
-
[Relationship between overexpression of HER-2/neu protein and prognosis in epithelial ovarian cancer].Nihon Rinsho. 2004 Oct;62 Suppl 10:582-6. Nihon Rinsho. 2004. PMID: 15535312 Review. Japanese. No abstract available.
Cited by
-
Lymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature.Mol Biol Rep. 2012 Dec;39(12):11153-65. doi: 10.1007/s11033-012-2024-y. Epub 2012 Oct 11. Mol Biol Rep. 2012. PMID: 23054001
-
Positive non-sentinel axillary lymph nodes in breast cancer with 1-2 sentinel lymph node metastases.Medicine (Baltimore). 2018 Nov;97(44):e13015. doi: 10.1097/MD.0000000000013015. Medicine (Baltimore). 2018. PMID: 30383658 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous